Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets – Update

Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets – Update

March 13, 2020

Please see our latest update here

Kyowa Kirin, the sole manufacturers of Nardil (phenelzine sulfate) 15mg tablets, are currently experiencing temporary disruptions.

Kyowa Kirin, the main supplier of Nardil (phenelzine sulfate) 15mg tablets have advised a delayed resupply date of March 2020. Supplies are available from specialist importers on an ‘unlicensed’ basis, and these companies listed below have advised they can continue to source unlicensed imports from abroad but the list is not exhaustive.

WEP Clinical

Ensure that where a prescriber wishes you to dispense an import, prescriptions are annotated ‘specials/unlicensed’ and are endorsed as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

SPS website which UK Medicine Information previously published about  management options including the need for specialist referral to mental health teams if unlicensed supplies of phenelzine sulfate 15mg tablets are deemed unsuitable

Posted in:

More Latest News >